This inventor holds 2 USPTO granted patents. Top assignee: Texas Biotechnology Corporation. Active years: 1995-1997.
Company Filing History:
Years Active: 1995-1997
Title: Huong Dao: Innovator in Biotechnology
Introduction
Huong Dao is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit the binding of E-selectin and P-selectin. With a total of 2 patents, her work has the potential to impact various medical conditions.
Latest Patents
Huong Dao's latest patents focus on compositions and methods for inhibiting the binding of E-selectin or P-selectin to sialyl-Lewis.sup.x or sialyl-Lewis.sup.a presented on cell surfaces. The first patent describes compounds that inhibit this binding, which can be utilized in treating conditions such as septic shock, ARDS, Crohn's disease, chronic inflammatory diseases, and cancer. The second patent further elaborates on the structural components of these compounds, detailing various chemical groups that can be employed in the inhibition process.
Career Highlights
Huong Dao is affiliated with Texas Biotechnology Corporation, where she continues to advance her research and innovations. Her work is crucial in developing therapeutic solutions for serious health issues, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Huong has collaborated with notable colleagues, including Brian Dupre and Timothy P Kogan. These partnerships have fostered a collaborative environment that enhances the research and development of innovative biotechnological solutions.
Conclusion
Huong Dao is a trailblazer in the biotechnology sector, with her inventions paving the way for new treatments for various diseases. Her contributions are invaluable, and her ongoing work promises to bring further advancements in medical science.